List of works - Morten Lock Hansen

Accuracy of the ICD-10 discharge diagnosis for syncope

scientific article published on 4 November 2012

Antiarrhythmic therapy and risk of death in patients with atrial fibrillation: a nationwide study.

scientific article published on 14 May 2009

Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients Taking an Oral Anticoagulant

scholarly article by Morten Lamberts et al published 15 April 2014 in Circulation

Antithrombotic treatment in patients with heart failure and associated atrial fibrillation and vascular disease: a nationwide cohort study

scientific article published on 30 April 2014

Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction.

scientific article

Atrial fibrillation pharmacotherapy after hospital discharge between 1995 and 2004: a shift towards beta-blockers

scientific article published on 7 February 2008

Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study

scientific article

Cardiovascular and non-cardiovascular hospital admissions associated with atrial fibrillation: a Danish nationwide, retrospective cohort study

scientific article published on 24 January 2013

Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin-A Nationwide Cohort Study

scientific article published on 29 October 2015

Clarithromycin use and risk of death in patients with ischemic heart disease

scientific article published on 05 June 2010

Comparison of incidence, predictors, and the impact of co-morbidity and polypharmacy on the risk of recurrent syncope in patients <85 versus ≥85 years of age.

scientific article published on 13 September 2013

Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study

scientific article

Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people

scientific article

Familial clustering and subsequent incidence of atrial fibrillation among first-degree relatives in Denmark

scientific article published on 10 November 2015

Increased short-term risk of thrombo-embolism or death after interruption of warfarin treatment in patients with atrial fibrillation

scientific article published on 23 December 2011

Infective endocarditis and risk of death after cardiac implantable electronic device implantation: a nationwide cohort study

scientific article published on 10 January 2017

Initiation and persistence with warfarin therapy in atrial fibrillation according to ethnicity

scientific article

Location of cardiac arrest in a city center: strategic placement of automated external defibrillators in public locations

scientific article

Major Bleeding Complications and Persistence With Oral Anticoagulation in Non-Valvular Atrial Fibrillation: Contemporary Findings in Real-Life Danish Patients

scientific article published on 14 February 2017

Management and prognosis of atrial fibrillation in the diabetic patient.

scientific article published on June 2015

Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study

scientific article published on 6 April 2011

Mortality and reinfarction among patients using different beta-blockers for secondary prevention after a myocardial infarction

scientific article published on 9 July 2008

NSAIDs are associated with increased risk of atrial fibrillation in patients with prior myocardial infarction: a nationwide study

scientific article

Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study

scientific article published on December 2014

New-onset atrial fibrillation is a predictor of subsequent hyperthyroidism: a nationwide cohort study

scientific article

Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.

scientific article

Obesity is a risk factor for atrial fibrillation among fertile young women: a nationwide cohort study

scientific article published on 2 January 2013

Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention

scientific article published on 7 June 2013

Oral anticoagulation therapy after radiofrequency ablation of atrial fibrillation and the risk of thromboembolism and serious bleeding: long-term follow-up in nationwide cohort of Denmark

scientific article published on 3 November 2014

Persistent Use of Evidence-Based Pharmacotherapy in Heart Failure Is Associated With Improved Outcomes

article

Prognosis among healthy individuals discharged with a primary diagnosis of syncope

scientific article published on 12 December 2012

Prognosis in heart failure and the value of {beta}-blockers are altered by the use of antidepressants and depend on the type of antidepressants used

scientific article published on 22 September 2009

Relation of nonsteroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy: a nationwide cohort study

scientific article published in November 2014

Reply: A persisting dilemma for triple antithrombotic therapy: are we close to finding the correct answer?

scientific article published on 5 February 2014

Response to letter regarding article, "Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study".

scientific article

Risk and benefit of dual antiplatelet treatment among non-revascularized myocardial infarction patients in different age groups

scientific article published on 16 June 2014

Risk of Myocardial Infarction in Anticoagulated Patients With Atrial Fibrillation

Risk of death and stroke associated with anticoagulation therapy after mitral valve repair

scientific article published on 4 January 2016

Risk of gastrointestinal adverse effects of dabigatran compared with warfarin among patients with atrial fibrillation: a nationwide cohort study

scientific article published on 19 May 2015

Subclinical and Overt Thyroid Dysfunction and Risk of All-Cause Mortality and Cardiovascular Events: A Large Population Study

Substantial differences in initiation of oral anticoagulant therapy and clinical outcome among non-valvular atrial fibrillation patients treated in inpatient and outpatient settings

scientific article

Temporal changes in patient characteristics and prior pharmacotherapy in patients undergoing radiofrequency ablation of atrial fibrillation: a Danish nationwide cohort study

scientific article published on 2 January 2013

Temporal trends in atrial fibrillation recurrence rates after ablation between 2005 and 2014: a nationwide Danish cohort study

scientific article

The pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people

scientific article published in August 2008

The relation between age, sex, comorbidity, and pharmacotherapy and the risk of syncope: a Danish nationwide study

scientific article published on 15 May 2012

The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study

scientific article

The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: A nationwide cohort study ⬇️

scientific article published on April 3, 2012

Thiazolidinediones are associated with a decreased risk of atrial fibrillation compared with other antidiabetic treatment: a nationwide cohort study

scientific article published on 8 November 2016

Thromboembolic risk in 16 274 atrial fibrillation patients undergoing direct current cardioversion with and without oral anticoagulant therapy.

scientific article published on 17 September 2014

Unexplained Syncope and Diagnostic Yield of Tests in Syncope According to the ICD-10 Discharge Diagnosis

scientific article published on 12 October 2013

Use and discontinuation of hormone replacement therapy in women with myocardial infarction: a nationwide study

scientific article published in January 2011

Use of oral anticoagulants in combination with antiplatelet(s) in atrial fibrillation

scientific article published in November 2017

Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study

scientific article

Vascular disease and stroke risk in atrial fibrillation: a nationwide cohort study

scientific article published on 10 May 2012

List of works by Morten Lock Hansen

Accuracy of the ICD-10 discharge diagnosis for syncope

Antiarrhythmic therapy and risk of death in patients with atrial fibrillation: a nationwide study.

Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients Taking an Oral Anticoagulant

Antithrombotic treatment in patients with heart failure and associated atrial fibrillation and vascular disease: a nationwide cohort study

Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction.

Atrial fibrillation pharmacotherapy after hospital discharge between 1995 and 2004: a shift towards beta-blockers

Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study

Cardiovascular and non-cardiovascular hospital admissions associated with atrial fibrillation: a Danish nationwide, retrospective cohort study

Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin-A Nationwide Cohort Study

Clarithromycin use and risk of death in patients with ischemic heart disease

Comparison of incidence, predictors, and the impact of co-morbidity and polypharmacy on the risk of recurrent syncope in patients <85 versus ≥85 years of age.

Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study

Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people

Familial clustering and subsequent incidence of atrial fibrillation among first-degree relatives in Denmark

Increased short-term risk of thrombo-embolism or death after interruption of warfarin treatment in patients with atrial fibrillation

Infective endocarditis and risk of death after cardiac implantable electronic device implantation: a nationwide cohort study

Initiation and persistence with warfarin therapy in atrial fibrillation according to ethnicity

Location of cardiac arrest in a city center: strategic placement of automated external defibrillators in public locations

Major Bleeding Complications and Persistence With Oral Anticoagulation in Non-Valvular Atrial Fibrillation: Contemporary Findings in Real-Life Danish Patients

Management and prognosis of atrial fibrillation in the diabetic patient.

Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study

Mortality and reinfarction among patients using different beta-blockers for secondary prevention after a myocardial infarction

NSAIDs are associated with increased risk of atrial fibrillation in patients with prior myocardial infarction: a nationwide study

Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study

New-onset atrial fibrillation is a predictor of subsequent hyperthyroidism: a nationwide cohort study

Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.

Obesity is a risk factor for atrial fibrillation among fertile young women: a nationwide cohort study

Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention

Oral anticoagulation therapy after radiofrequency ablation of atrial fibrillation and the risk of thromboembolism and serious bleeding: long-term follow-up in nationwide cohort of Denmark

Persistent Use of Evidence-Based Pharmacotherapy in Heart Failure Is Associated With Improved Outcomes

Prognosis among healthy individuals discharged with a primary diagnosis of syncope

Prognosis in heart failure and the value of {beta}-blockers are altered by the use of antidepressants and depend on the type of antidepressants used

Relation of nonsteroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy: a nationwide cohort study

Reply: A persisting dilemma for triple antithrombotic therapy: are we close to finding the correct answer?

Response to letter regarding article, "Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study".

Risk and benefit of dual antiplatelet treatment among non-revascularized myocardial infarction patients in different age groups

Risk of Myocardial Infarction in Anticoagulated Patients With Atrial Fibrillation

Risk of death and stroke associated with anticoagulation therapy after mitral valve repair

Risk of gastrointestinal adverse effects of dabigatran compared with warfarin among patients with atrial fibrillation: a nationwide cohort study

Subclinical and Overt Thyroid Dysfunction and Risk of All-Cause Mortality and Cardiovascular Events: A Large Population Study

Substantial differences in initiation of oral anticoagulant therapy and clinical outcome among non-valvular atrial fibrillation patients treated in inpatient and outpatient settings

Temporal changes in patient characteristics and prior pharmacotherapy in patients undergoing radiofrequency ablation of atrial fibrillation: a Danish nationwide cohort study

Temporal trends in atrial fibrillation recurrence rates after ablation between 2005 and 2014: a nationwide Danish cohort study

The pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people

The relation between age, sex, comorbidity, and pharmacotherapy and the risk of syncope: a Danish nationwide study

The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study

The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: A nationwide cohort study ⬇️

Thiazolidinediones are associated with a decreased risk of atrial fibrillation compared with other antidiabetic treatment: a nationwide cohort study

Thromboembolic risk in 16 274 atrial fibrillation patients undergoing direct current cardioversion with and without oral anticoagulant therapy.

Unexplained Syncope and Diagnostic Yield of Tests in Syncope According to the ICD-10 Discharge Diagnosis

Use and discontinuation of hormone replacement therapy in women with myocardial infarction: a nationwide study

Use of oral anticoagulants in combination with antiplatelet(s) in atrial fibrillation

Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study

Vascular disease and stroke risk in atrial fibrillation: a nationwide cohort study